Literature DB >> 25845678

Falls in ambulatory non-demented patients with Parkinson's disease.

Olivier Rascol1,2,3, Santiago Perez-Lloret4,5, Philippe Damier6,7, Arnaud Delval8, Pascal Derkinderen9, Alain Destée10,11,12, Wassilios G Meissner13,14,15, Francois Tison16,17,18,19, Laurence Negre-Pages20,21.   

Abstract

This study aimed at determining the prevalence of falling in PD patients, to assess generic and disease-specific clinical and pharmacological factors, relationship with health-related quality of life (HR-QoL) and changes in falls from OFF to ON in patients with motor fluctuations. Six-hundred and eighty-three PD patients of the COPARK survey were evaluated (11 had missing data and were excluded from the analysis). Patients with falls were identified as those with a UPDRS Item 13 ≥ 1 in the ON condition. All patients were assessed in a standardized manner [demographics, treatments, Unified PD Rating Scale (UPDRS), Hospital Anxiety and Depression Scale, Pittsburg questionnaire and HR-QoL scales (SF36, PDQ39)]. Falling was reported by 108/672 (16%) PD patients during the ON state and prevalence increased according to PD severity, from 5% in Hoehn and Yahr stage 1-60% in stage 4. Falling was significantly related to lower HR-QoL. Falling correlated with (1) generic factors such as female gender, age at the end of academic studies and diuretics consumption, (2) motor PD-specific factors including disease severity, frozen gait, difficulties when arising from a chair, dyskinesia and higher levodopa daily equivalent dose and (3) non-motor PD-specific factors such as orthostatic hypotension and hallucinations. Falling was more frequent in OFF than in ON in 48/74 (64%) patients with motor fluctuations and remained unchanged in 27 patients (36%). In summary, falling affected a significant proportion of PD patients, especially in advanced stages. It was associated with a variety of generic and PD-specific factors and was related to reduced HR-QoL.

Entities:  

Keywords:  Falls; Gait disorders; Hallucinations; Orthostatic hypotension; Parkinson’s disease; Quality of life

Mesh:

Substances:

Year:  2015        PMID: 25845678     DOI: 10.1007/s00702-015-1396-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  26 in total

1.  Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up study.

Authors:  M Matinolli; J T Korpelainen; K A Sotaniemi; V V Myllylä; R Korpelainen
Journal:  Acta Neurol Scand       Date:  2011-03       Impact factor: 3.209

2.  Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39)

Authors:  C Jenkinson; V Peto; R Fitzpatrick; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1995-11       Impact factor: 10.668

3.  Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

Authors:  B H Wood; J A Bilclough; A Bowron; R W Walker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

4.  Falls in Parkinson's disease. Causes and impact on patients' quality of life.

Authors:  Małgorzata Michałowska; Urszula Fiszer; Anna Krygowska-Wajs; Krzysztof Owczarek
Journal:  Funct Neurol       Date:  2005 Oct-Dec

Review 5.  Parkinson's disease patients who fracture their neck of femur: a review of outcome data.

Authors:  V J Clubb; S E Clubb; S Buckley
Journal:  Injury       Date:  2006-02-17       Impact factor: 2.586

6.  Orthostatic hypotension, balance and falls in Parkinson's disease.

Authors:  Maarit Matinolli; Juha T Korpelainen; Raija Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

7.  Factors related to orthostatic hypotension in Parkinson's disease.

Authors:  Santiago Perez-Lloret; María Verónica Rey; Nelly Fabre; Fabienne Ory; Umberto Spampinato; Jean-Michel Senard; Anne Pavy-Le Traon; Jean-Louis Montastruc; Olivier Rascol
Journal:  Parkinsonism Relat Disord       Date:  2012-02-13       Impact factor: 4.891

8.  A meta-analysis of six prospective studies of falling in Parkinson's disease.

Authors:  Ruth M Pickering; Yvette A M Grimbergen; Una Rigney; Ann Ashburn; Gordon Mazibrada; Brian Wood; Peggy Gray; Graham Kerr; Bastiaan R Bloem
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

9.  Recurrent falls in Parkinson's disease: a systematic review.

Authors:  Natalie E Allen; Allison K Schwarzel; Colleen G Canning
Journal:  Parkinsons Dis       Date:  2013-03-05

10.  Effect of dopaminergic medication on postural sway in advanced Parkinson's disease.

Authors:  Fredy J Revilla; Travis R Larsh; Ashutosh Mani; Andrew P Duker; Cyndy Cox; Paul Succop; Maureen Gartner; Claudia Jarrin Tejada; Amit Bhattacharya
Journal:  Front Neurol       Date:  2013-12-13       Impact factor: 4.003

View more
  20 in total

1.  Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Semin Neurol       Date:  2020-09-09       Impact factor: 3.420

2.  Utilization Patterns of Amantadine in Parkinson's Disease Patients Enrolled in the French COPARK Study.

Authors:  Olivier Rascol; Laurence Negre-Pages; Philippe Damier; Arnaud Delval; Pascal Derkinderen; Alain Destée; Margherita Fabbri; Wassilios G Meissner; Amine Rachdi; François Tison; Santiago Perez-Lloret
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

3.  ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.

Authors:  Rajesh Pahwa; Caroline M Tanner; Robert A Hauser; Stuart H Isaacson; Paul A Nausieda; Daniel D Truong; Pinky Agarwal; Keith L Hull; Kelly E Lyons; Reed Johnson; Mary Jean Stempien
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

Review 4.  Interventions for preventing falls in Parkinson's disease.

Authors:  Natalie E Allen; Colleen G Canning; Lorena Rosa S Almeida; Bastiaan R Bloem; Samyra Hj Keus; Niklas Löfgren; Alice Nieuwboer; Geert Saf Verheyden; Tiê P Yamato; Catherine Sherrington
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

Review 5.  Autonomic Dysfunction in Parkinson's Disease.

Authors:  Ronald F Pfeiffer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

6.  Office orthostatic blood pressure measurements and ambulatory blood pressure monitoring in the prediction of autonomic dysfunction.

Authors:  Kawther F Alquadan; Girish Singhania; Abhilash Koratala; Abutaleb A Ejaz
Journal:  Clin Hypertens       Date:  2017-03-15

7.  Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's Disease.

Authors:  Kathryn A Chung; Brenna M Lobb; Charles F Murchison; Martina Mancini; Penelope Hogarth; John G Nutt
Journal:  Mov Disord Clin Pract       Date:  2018-03-02

8.  Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease.

Authors:  Alessandra Fanciulli; Nicole Campese; Georg Goebel; Jean Pierre Ndayisaba; Sabine Eschlboeck; Christine Kaindlstorfer; Cecilia Raccagni; Roberta Granata; Ubaldo Bonuccelli; Roberto Ceravolo; Klaus Seppi; Werner Poewe; Gregor K Wenning
Journal:  Neurology       Date:  2020-09-16       Impact factor: 9.910

9.  Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson's Disease.

Authors:  Márton Kovács; Attila Makkos; Zsuzsanna Aschermann; József Janszky; Sámuel Komoly; Rita Weintraut; Kázmér Karádi; Norbert Kovács
Journal:  Parkinsons Dis       Date:  2016-05-16

10.  Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension.

Authors:  Robert A Hauser; Stephane Heritier; Gerald J Rowse; L Arthur Hewitt; Stuart H Isaacson
Journal:  Clin Neuropharmacol       Date:  2016 Sep-Oct       Impact factor: 1.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.